ByteDance's Anew Labs unveils AI‑designed drug candidates at international conferences
Fast facts
- Category: Asia
- Language: EN
- Published: 2026-05-02 03:00 UTC
- Sources: South China Morning Post
ByteDance’s drug‑discovery arm, Anew Labs (also known as Anew Therapeutics), presented several AI‑generated therapeutic candidates at global scientific meetings. Operating from Shanghai, Singapore and San Jose, the unit lists 36 core scientists and a high‑profile advisory board that includes noted researchers. The move signals ByteDance’s push to expand beyond social media into biotech.